Similar enzymes, different mechanisms: COX-1 and COX-2 enzymes in neurologic disease

Archives of Neurology

Volumn 60, Issue 4, 2003, Pages 632-633

  DeKosky, Steven T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE PRODUCT;

APOPTOSIS; ARTICLE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME MECHANISM; INFLAMMATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NERVOUS SYSTEM DISEASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0037386963     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.4.632     Document Type: Article

References (2)

1. Aisen PS, Schafer K, Grundman M, et al. for the Alzheimer's Disease Cooperative Study. A multicenter trial of rofecoxib and naproxen in Alzheimer's disease. Paper presented at: the Interna tional Conference on Alzheimer's Disease; July 24, 2002; Stockholm, Sweden.
2. in't Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001;21:1515-1521.